Page last updated: 2024-08-21

ethyl pyruvate and Liver Neoplasms

ethyl pyruvate has been researched along with Liver Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, K; Cheng, P; Dai, W; Guo, CY; Li, J; Lu, J; Shen, M; Wang, C; Wang, F; Xu, L; Yang, J; Zhang, H; Zhang, Y; Zheng, Y; Zhu, R	1
Beer-Stolz, D; Davé, SH; DeMarco, RA; Fink, MP; Li, F; Lotze, MT; Matsuoka, K; Plevy, SE; Sepulveda, AR; Tilstra, JS	1

Other Studies

2 other study(ies) available for ethyl pyruvate and Liver Neoplasms

Article	Year
Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Biochemical and biophysical research communications, 2014, Jan-24, Volume: 443, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycation End Products, Advanced; Hep G2 Cells; HMGB1 Protein; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Signal Transduction; Xenograft Model Antitumor Assays	2014
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. Journal of leukocyte biology, 2009, Volume: 86, Issue:3 Topics: Adenocarcinoma; Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein-5-isothiocyanate; HMGB1 Protein; In Situ Nick-End Labeling; Interleukin-10; Interleukin-12 Subunit p40; Intestinal Mucosa; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyruvates; Random Allocation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transfection	2009

Article

Year

Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.

Biochemical and biophysical research communications, 2014, Jan-24, Volume: 443, Issue:4

Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycation End Products, Advanced; Hep G2 Cells; HMGB1 Protein; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Signal Transduction; Xenograft Model Antitumor Assays

2014

Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.

Journal of leukocyte biology, 2009, Volume: 86, Issue:3

Topics: Adenocarcinoma; Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein-5-isothiocyanate; HMGB1 Protein; In Situ Nick-End Labeling; Interleukin-10; Interleukin-12 Subunit p40; Intestinal Mucosa; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyruvates; Random Allocation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transfection

2009